Hemorrhagic Macular Infarction after Intravitreal Bevacizumab for Chronic Multifocal Central Serous Chorioretinopathy

Hemorrhagic Macular Infarction after Intravitreal Bevacizumab for Chronic Multifocal Central Serous Chorioretinopathy

We hereby report a case of hemorrhagic macular infarction after intravitreal bevacizumab for chronic multifocal central serous chorioretinopathy (CSC). Issues regarding safety and adverse effects of bevacizumab are discussed. To the best of our knowledge, this is the first reported case of hemorrhag...

Full description

Bibliographic Details
Main Authors: Kelkar, Aditya, Gandhi, Poonam, Amoaku, Winfried, Kelkar, Jai, Kelkar, Shreekant, Raut, Priyanka, Shah, Rachana
Format: Online
Language:English
Published: S. Karger AG 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130817/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130817/

Similar Items